Managing Adverse Events and Supportive Care Measures in CLL Treatment

Opinion
Video

The discussion covers proactive strategies and interventions for managing adverse events before dose modification and explores supportive care measures for chronic lymphocytic leukemia treatments, including variations based on specific Bruton tyrosine kinase inhibitors.

Video content above is prompted by the following:

  • What proactive strategies and interventions are used to manage adverse events before resorting to dose modification?
  • What supportive care measures are typically implemented to manage adverse events in chronic lymphocytic leukemia treatments and do these vary based on the specific Bruton tyrosine kinase inhibitor?
Recent Videos
Related Content